1,308
Participants
Start Date
October 27, 2022
Primary Completion Date
October 27, 2023
Study Completion Date
October 27, 2023
Quadrivalent Recombinant influenza vaccine (RIV4) season/2022-2023/NH
Pharmaceutical form: Solution for injection Route of administration: intramuscular
Velocity Clinical Research Vestal Site Number : 8400016, Vestal
Meridian Clinical Research Site Number : 8400006, Binghamton
Velocity Clinical Research Portsmouth Site Number : 8400015, Portsmouth
Investigational Site Number : 7240018, Madrid
Investigational Site Number : 7240001, Móstoles
Investigational Site Number : 7240005, Málaga
Coastal Carolina Research Center - N Charleston Site Number : 8400022, North Charleston
Coastal Pediatric Research Charleston Site Number : 8400005, Charleston
Rainbow Pediatrics Site Number : 8400014, Barnwell
Alabama Clinical Therapeutics North Tower Site Number : 8400024, Birmingham
Birmingham Pediatric Associates Site Number : 8400023, Birmingham
Investigational Site Number : 2030001, Jindřichův Hradec
Kentucky Pediatics / Adult Research Site Number : 8400010, Bardstown
Investigational Site Number : 7240007, Seville
Ohio Pediatric Research Site Number : 8400020, Dayton
Meridian Clinical Research- Sioux City Site Number : 8400007, Sioux City
AMR - Newton Site Number : 8400021, Newton
Velocity Clinical Research, Omaha Site Number : 8400009, Omaha
Velocity Clinical Research Lincoln Site Number : 8400013, Lincoln
Meridian Clinical Research Norfolk Site Number : 8400011, Norfolk
Velocity Clinical Research Site Number : 8400012, New Orleans
The Children's Clinic Of Jonesboro PA Site Number : 8400025, Jonesboro
Benchmark Research - Austin Site Number : 8400004, Austin
JBR Clinical Research Site Number : 8400001, Salt Lake City
J. Lewis Research Site Number : 8400017, Salt Lake City
California Research Foundation Site Number : 8400003, San Diego
Investigational Site Number : 6160010, Bydgoszcz
Investigational Site Number : 6160007, Bydgoszcz
Investigational Site Number : 6160004, PuÅ'awy
Investigational Site Number : 6160005, Siemianowice Śląskie
Investigational Site Number : 6160003, Bydgoszcz
Investigational Site Number : 6160006, Tarnów
Investigational Site Number : 6160008, Warsaw
Investigational Site Number : 6160012, Wroclaw
Investigational Site Number : 7240006, Centelles
Sanofi Pasteur, a Sanofi Company
INDUSTRY